API reference

Dimethyl fumarate

CAS number
624-49-7
Molecular formula
C6H8O4
Molecular weight
144.12 g/mol
Dimethyl fumarate — 2D structure
2D structure (PubChem)

About this molecule

Dimethyl fumarate is an agent indicated for the treatment of relapsing forms of multiple sclerosis. The mechanism of action of dimethyl fumarate in multiple sclerosis is not well understood. It is thought to involve dimethyl fumarate degradation to its active metabolite monomethyl fumarate (MMF) then MMF up-regulates the Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) pathway that is activated in response to oxidative stress. Dimethyl fumarate is marketed under the brand name Tecfidera, and it was the third oral disease-modifying agent for multiple sclerosis approved by the FDA, following [fingolimod] and [teriflunomide]. Prior to its FDA approval, dimethyl fumarate had been used in Germany for treatment of psoriasis.

Source: DrugBank, via PubChem.

Identifiers

IUPAC name
dimethyl (E)-but-2-enedioate
InChIKey
LDCRTTXIJACKKU-ONEGZZNKSA-N
SMILES
COC(=O)/C=C/C(=O)OC
Other CAS numbers recorded
23055-10-9 · 12287-98-8
PubChem CID
637568

Also known as

Dimethyl fumarate · Tecfidera · Fumaric acid dimethyl ester · Fumaderm · Dimethylfumarate · Fumaric acid, dimethyl ester · BG-12 · Panaclar

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com